Danaher Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
Danaher Stock Forecast and Price Target
The average target price for Danaher's stock set by four renowned analysts in recent months is $270.00, representing a potential upside of approximately 12.79% from its last closing price if met by 2025. This estimation is based on a high estimate of $300.00 and a low estimate of $208.00. Although you may not be interested in DHR stock, you should still be aware of its competitors.
12.79% Upside
Danaher Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Danaher has seen a decline in its Price, from $165.39 to $0.00 – a 100.00% decrease. In the next year, analysts predict that Fair Value will jump to $315.04 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AVGO Stock Forecast | Broadcom | Outperform |
8
|
$1.28k | Buy/Sell | $1.21k | 21.24% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$105.90 | Buy/Sell | $118.92 | 19.92% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$264.07 | Buy/Sell | $303.65 | 20.14% |
| ETN Stock Forecast | Eaton | Outperform |
13
|
$310.18 | Buy/Sell | $246.22 | 1.88% |
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$67.96 | Buy/Sell | $70.14 | 7.42% |
Danaher Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Danaher's Revenue has grown, moving from $22.28B to $23.89B – an increase of 7.21%. In the next year, analysts predict that Revenue will jump to $34.95B – up 46.29% from the current level. Looking ahead to seven years, experts forecast that Revenue will grow by 65.47%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$47.84 | Buy/Sell | $58.15 | 14.97% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$232.21 | Buy/Sell | $284.47 | 20.58% |
| EMR Stock Forecast | Emerson Electric Co | Outperform |
10
|
$109.81 | Buy/Sell | $109.83 | 13.03% |
.jpg)
Danaher Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Danaher's Dividend per Share has seen an increase, rising from $0.72 to $1.05. This represents a growth of 45.83%. Analysts predict that Danaher's Dividend per Share will increase in the upcoming year, reaching $1.28. This would represent an increase of 21.90%. Over the next seven years, experts predict that Danaher's Dividend per Share will grow at a rate of 68.06%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ECL Stock Forecast | Ecolab | Hold |
18
|
$219.25 | Buy/Sell | $205.36 | 5.36% |
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$87.24 | Buy/Sell | $91.18 | 11.19% |
| MMM Stock Forecast | 3M | Hold |
10
|
$90.96 | Buy/Sell | $109.39 | 9.94% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| F Stock Forecast | Ford Motor | Hold |
9
|
$12.04 | Buy/Sell | $13.42 | 7.97% |
| AME Stock Forecast | AMETEK | Outperform |
10
|
$178.05 | Buy/Sell | $180.64 | 9.52% |
| A Stock Forecast | Agilent Technologies | Outperform |
10
|
$134.55 | Buy/Sell | $138.82 | 12.60% |
Danaher EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, EBITDA for Danaher has grown by 13.72%, going from $6.48B to $7.37B. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach $12.25B – an increase of 66.30%. Over the next seven years, experts anticipate that EBITDA growth for Danaher will be 77.38%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DOW Stock Forecast | Dow | Hold |
2
|
$56.82 | Buy/Sell | $57.75 | 5.60% |
| ALC Stock Forecast | Alcon | Outperform |
8
|
CHF72.00 | Buy/Sell | CHF90.64 | 33.83% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$192.16 | Buy/Sell | $299.62 | 51.96% |
Danaher EBIT Forecast for 2023 - 2025 - 2030
Danaher's EBIT has grown in the last three years, jumping from $4.70B to $5.20B – an increase of 10.59%. In the next year, analysts predict that EBIT will reach $9.61B – an increase of 84.72%. For the next seven years, the forecast is for EBIT to grow by 111.89%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAYN Stock Forecast | Bayer | Hold |
5
|
26.25€ | Buy/Sell | 45.15€ | 21.90% |
| GLW Stock Forecast | Corning | Outperform |
17
|
$30.98 | Buy/Sell | $32.81 | 12.98% |
| 7751 Stock Forecast | Canon | Hold |
18
|
¥4.28k | Buy/Sell | ¥3.74k | -11.24% |
Danaher EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Danaher has seen a decline in its EPS, from $6.31 to $0.00 – a 100.00% decrease. In the next year, analysts predict that EPS will jump to $12.02 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DOV Stock Forecast | Dover | Outperform |
18
|
$169.50 | Buy/Sell | $167.07 | 6.19% |
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$39.52 | Buy/Sell | $44.86 | 13.87% |
| ENTG Stock Forecast | Entegris | Outperform |
18
|
$129.25 | Buy/Sell | $116.12 | 13.73% |
.jpg)